ATYR Pharma(ATYR.US)

Last Updated 19:00:00 ET
longbridge loading

RBC Capital Sticks to Its Hold Rating for aTyr Pharma (ATYR)

Tip Ranks·
US
ATYR
+0.17%
US
SBIO
-0.32%
US
IBB
+0.55%
Tip Ranks·
US
ATYR
+0.17%
US
SBIO
-0.32%
US
IBB
+0.55%

ATYR Pharma | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
ATYR
+0.17%
Earnings Watch·
US
ATYR
+0.17%

ATYR Pharma | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
ATYR
+0.17%
Earnings Watch·
US
ATYR
+0.17%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga_article·
US
QUCY
-15.15%
US
STAA
+2.63%
US
ALP
-4.13%
benzinga_article·
US
QUCY
-15.15%
US
STAA
+2.63%
US
ALP
-4.13%

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga_article·
US
SMTI
+2.56%
US
ATYR
+0.17%
US
ERNA
-10.24%
benzinga_article·
US
SMTI
+2.56%
US
ATYR
+0.17%
US
ERNA
-10.24%

aTyr Pharma (ATYR) Receives a Hold from Wells Fargo

Tip Ranks·
US
ATYR
+0.17%
Tip Ranks·
US
ATYR
+0.17%

aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial

Market Beat·
US
ATYR
+0.17%
US
BBH
+1.02%
US
IBB
+0.55%
Market Beat·
US
ATYR
+0.17%
US
BBH
+1.02%
US
IBB
+0.55%

12 Health Care Stocks Moving In Monday's After-Market Session

benzinga_article·
US
PACS
-1.77%
US
WOK
-38.55%
US
ABCL
-3.00%
benzinga_article·
US
PACS
-1.77%
US
WOK
-38.55%
US
ABCL
-3.00%
© 2026 Longbridge｜Disclaimer